Experiment summary for ENCSR971QHH
doi:10.17989/ENCSR971QHH
Alternate accession: ENCSR214OTU
Summary
- Status
- released
- Assay
- ChIP-seq (Histone ChIP-seq)
- Target
- H3K4me1
- Biosample summary
- Homo sapiens CD4-positive, alpha-beta T cell treated with phorbol 13-acetate 12-myristate, ionomycin
- Biosample Type
- primary cell
- Replication type
- anisogenic
- Treatments
- phorbol 13-acetate 12-myristate (CHEBI:37537) , ionomycin (CHEBI:63954)
- Nucleic acid type
- DNA
- Platform
- Illumina HiSeq 2000
- Controls
Attribution
Roadmap Epigenomics Mapping Consortium
- Lab
- Bradley Bernstein, Broad
- Award
- U01ES017155 (Bradley Bernstein, Broad)
- Project
- Roadmap
- External resources
- Aliases
- roadmap-epigenomics:ChIP-Seq analysis of H3K4me1 in human CD25- IL17- Th stim MACS cells_Jul-30-2011_984, roadmap-epigenomics:ChIP-Seq analysis of H3K4me1 in human CD25- IL17- Th stim MACS cells_Jun-28-2012_82711
- Date submitted
- July 31, 2013
- Date released
- July 31, 2013
- Reference Epigenome
- ENCSR832UFG
- Submitter comment
- The raw data from at least one replicate is not available to the ENCODE consortium.
- Tags
Anisogenic replicates
Anisogenic replicate | Technical replicate | Summary | Biosample | Antibody | Library |
|---|---|---|---|---|---|
| 1 | 3 | Homo sapiens CD4-positive, alpha-beta T primary cell treated with phorbol 13-acetate 12-myristate, ionomycin | ENCBS182XKP | ENCAB000APS | ENCLB677UTA |
| 2 | 2 | Homo sapiens CD4-positive, alpha-beta T primary cell treated with phorbol 13-acetate 12-myristate, ionomycin | ENCBS061FHJ | ENCAB000APS | ENCLB101DAG |